FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Sunday, June 3, 2018
FDA wants to shorten new drug monopolies to cut costs
FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Related Posts:
Disney agrees to sell Fox Sports in Brazil to win antitrust nod- Wells Fargo starts settlement talks with Justice Dept, SEC
- Southwest Airlines wins U.S. approval for Hawaii service
- Apple self-driving car layoffs give hints to division's direction
- PG&E delayed key power line safety overhaul, filings show; shares slip
0 comments:
Post a Comment